UK-based Cell Medica Ltd has appointed Alain Pralong, a former executive of GSK Vaccines in Belgium, as head of manufacturing operations for its cellular immunotherapies for cancer and infections. Dr Pralong will execute the company’s strategy for supplying patient-specific cell products globally. He will also oversee the company’s contract manufacturing relationships.
Also joining the company is Stefanos Theoharis as head of pipeline strategy and corporate partnering. Dr Theoharis is the former chief business officer at apceth GmbH, a German cell therapy company. He has previous business development experience at Antisense Pharma (now Isarna Therapeutics) and at Roche..
Cell Medica announced the appointments on 24 May 2016.
Copyright 2016 Evernow Publishing Ltd